References
- WeleberRGWatzkeRCShultsWTClinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodiesAm J Ophthalmol2005139578079415860281
- HeckenlivelyJRFerreyraHAAutoimmune retinopathy: a review and summarySemin Immunopathol200830212713418408929
- AdamusGAutoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathyAutoimmun Rev200322636812848960
- AdamusGRenGWeleberRGAutoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathyBMC Ophthalmol200441915018630
- GrangeLDalalMNussenblattRBSenHNAutoimmune retinopathyAm J Ophthalmol2014157226627224315290
- FerreyraHAJayasunderaTKhanNWManagement of autoimmune retinopathies with immunosuppressionArch Ophthalmol2009127439039719365013
- RahimyESarrafDParaneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and managementSurv Ophthalmol201358543045823969019
- SawyerRASelhorstJBZimmermanLEHoytWFBlindness caused by photoreceptor degeneration as a remote effect of cancerAm J Ophthalmol1976815606613179323
- MurphyMAThirkillCEHartWMJrParaneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinomaJ Neurophthalmol19971727783
- GuyJAptsiauriNTreatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 casesArch Ophthalmol1999117447147710206574
- DyIChintapatlaRPreeshagulIBeckerDTreatment of cancer-associated retinopathy with rituximabJ Natl Compr Canc Netw201311111320132424225966
- OrCCollinsDRMerkurABIntravenous rituximab for the treatment of cancer-associated retinopathyCan J Ophthalmol2013482e35e3823561621
- FoxAJeffreyBHasniSNussenblattRSenHNRituximab treatment for nonparaneoplastic autoimmune retinopathyCan J Ophthalmol2015506e101e10426651312
- GrewalDSFishmanGAJampolLMAutoimmune retinopathy and antiretinal antibodies: a reviewRetina201434582784524646664
- MalekiASwanRTSilpa-ArchaSShort-wavelength automated perimetry parameters at baseline and following remission in patients with birdshot retinochoroidopathyAm J Ophthalmol201616383.e692.e626621683
- KeltnerJLJohnsonCABeckRWClearyPASpurrJOQuality control functions of the visual field reading center (VFRC) for the Optic Neuritis Treatment Trial (ONTT)Control Clin Trials19931421431598500303
- KeltnerJLJohnsonCASpurrJOBeckRWOptic Neuritis Study GroupBaseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trialArch Ophthalmol199311122312348431161
- AlencarLMMedeirosFAThe role of standard automated perimetry and newer functional methods for glaucoma diagnosis and follow-upIndian J Ophthalmol2011Suppl 59S53S5821150035
- LiuSLamSWeinrebRNComparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucomaInvest Ophthalmol Vis Sci201152107325733121810975
- FosterCSChangPYAhmedARCombination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary reportOphthalmology2010117586186920045562
- CaoJHOrayMCochoLFosterCSRituximab in the treatment of refractory noninfectious scleritisAm J Ophthalmol2016164222826766304
- MillsRPBudenzDLLeePPCategorizing the stage of glaucoma from pre-diagnosis to end-stage diseaseAm J Ophthalmol20061411243016386972
- FishmanGAChappelowAVAndersonRJRotenstreichYDerlackiDJShort-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosaRetina20052581014102116340532
- JampolLMFishmanGAImmunosuppression for autoimmune retinopathyArch Ophthalmol2009127457357519365043
- FaezSLoewensteinJSobrinLConcordance of antiretinal antibody testing results between laboratories in autoimmune retinoapathyJAMA Ophthalmol2013131111311523307224